News and Publications
Publication Categories
Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease
Discover how 7HP349, a novel integrin activator, enhances vaccine efficacy by boosting T cell-mediated immune responses. Learn how this systemic adjuvant improves protection against Chagas disease and other infections.